Stevanato Group S.p.A.(STVN) Stock Research - Grey Stern Research
Loading...

Stevanato Group S.p.A. (STVN) Stock Analysis

$22.51 (3.88%)

STVN Financial Performance


Use the table below to view Stevanato Group S.p.A.'s financial profile. This data is gathers from the latest available financial statements. Annual data is taken from the trailing 12 months of statements. All numbers are reported in US Dollars and so any foreign currencies are converted to USD so comparison's can be done.

Based on Financial Statements from Q4 - 2024

Metric Value Ranking among Peers
Price $21.67 -
52 Week Low $16.56 -
52 Week High $33.49 -
Market Cap $7.0 Billion 5/14
Gross Margin 30% 14/14
Profit Margin 15% 3/14
EBITDA margin 20% 4/14
Q4 - 2024 Revenue $363.3 Million 9/14
Q4 - 2024 Earnings $53.1 Million 5/14
Q4 - 2024 Free Cash Flow $36.7 Million 6/14
Trailing 4 Quarters Revenue $1.2 Billion 11/14
Trailing 4 Quarters Earnings $129.5 Million 6/14
Quarterly Earnings Growth 10% 8/14
Annual Earnings Growth -25% 10/14
Quarterly Revenue Growth 6% 7/14
Annual Revenue Growth -2% 9/14
Cash On Hand $108.0 Million 11/14
Short Term Debt $123.0 Million 3/14
Long Term Debt $348.4 Million 10/14

Stevanato Group S.p.A. Financial Metrics


Financial metrics are a set of useful numbers that can give key performance indicators of a company. The various metrics can include information about profitability, growth, and debt load. When combined and use properly they can tell an analyst a compelling fact-based story of how the company is currently performing. To compare Stevanato Group S.p.A.'s metrics versus it's peers make sure to run our peer analysis tool.

Valuation Metrics

Metric Value Ranking among Peers
PE 53.96 2/14
PS 5.23 4/14
PB 4.53 4/14
PC 64.72 2/14
Liabilities to Equity 0.66 8/14
ROA 0.06 4/14
ROE 0.09 5/14
Current Ratio 2.52 6/14
Quick Ratio 0.11 11/14
Long Term Debt to Equity 0.23 10/14
Debt to Equity 0.31 9/14
Burn Rate -7.91 13/14
Cash to Cap 0.02 11/14
CCR 0.69 5/14
EV to EBITDA 118.48 2/14
EV to Revenue 6.59 2/14

Company Details

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. operates as a subsidiary of Stevanato Holding S.R.L.

CEO:

Website: https://www.stevanatogroup.com

Address: Via Molinella, 17 Piombino Dese, PD

Exchange: New York Stock Exchange

Industry: Medical Instruments & Supplies

Stevanato Group S.p.A. Peer Analysis


A useful and more reliable way of seeing the health of a company is to compare it to other companies operating in the same sector. Below is our list of companies which we rank are the closest peers to Stevanato Group S.p.A.. If you feel that peers should be added or removed from this list please contact us. To run an in-depth peer analysis which compares many financial metrics click on the link below.

Stock Ticker Market Cap
DENTSPLY SIRONA Inc. XRAY $3.1 Billion
ResMed Inc. RMD $32.3 Billion
The Cooper Companies, Inc. COO $16.3 Billion
Haemonetics Corporation HAE $3.2 Billion
Teleflex Incorporated TFX $6.6 Billion
West Pharmaceutical Services, Inc. WST $16.5 Billion
Merit Medical Systems, Inc. MMSI $6.0 Billion
AngioDynamics, Inc. ANGO $401.4 Million
ICU Medical, Inc. ICUI $3.6 Billion
AptarGroup, Inc. ATR $9.6 Billion
AtriCure, Inc. ATRC $1.6 Billion
Envista Holdings Corporation NVST $2.9 Billion
Akoya Biosciences, Inc. AKYA $84.3 Million
Run Peer Analysis
Income Statement
Balance Sheet
Cash Flow Statement
STVN Income Statements
Quarter Year Revenue Earnings
Q4 2024 € 330.6 Million €48.3 Million
Q3 2024 € 277.9 Million €30.0 Million
Q2 2024 € 260.9 Million €20.7 Million
Q1 2024 € 237.4 Million €18.8 Million
Q4 2023 € 312.4 Million €44.0 Million
Q3 2023 € 271.4 Million €37.9 Million
Q2 2023 € 255.3 Million €34.3 Million
Q1 2023 € 238.0 Million €28.3 Million

View All

STVN Balance Sheets
Quarter Year Cash & Equivalents Total Assets Total Debt Total Equity
Q4 2024 €98.3 Million €2.3 Billion €429.0 Million €1.4 Billion
Q3 2024 €78.0 Million €2.2 Billion €361.8 Million €1.3 Billion
Q2 2024 €78.1 Million €2.2 Billion €319.1 Million €1.3 Billion
Q1 2024 €186.5 Million €2.2 Billion €374.3 Million €1.3 Billion
Q4 2023 €69.7 Million €2.1 Billion €399.2 Million €1.1 Billion
Q3 2023 €0 €0 €0 €1.1 Billion
Q2 2023 €0 €0 €0 €1.1 Billion
Q1 2023 $158.8 Million $1.7 Billion $227.5 Million $1.0 Billion

View All

STVN Cash Flow Statements
Quarter Year freeCashFlow capitalExpenditure netChangeInCash
Q4 2024 €33.4 Million €80.4 Million €20.3 Million
Q3 2024 -€110.2 Million -€222.4 Million €8.4 Million
Q2 2024 €21.7 Million €0 -€108.4 Million
Q1 2024 -€31.3 Million -€103.3 Million €116.8 Million
Q4 2023 €8.9 Million €0 €4.7 Million
Q3 2023 €33.5 Million €0 €3.0 Million
Q2 2023 €24.4 Million €0 -€96.9 Million
Q1 2023 -€91.6 Million -€128.8 Million -€70.0 Million

View All